Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,602 | 19,363 | 19,731 | 19,084 | 7,350 |
| Receivables | 2,336 | 879 | 4,671 | 7,245 | N/A |
| Other current assets | 0 | 0 | 0 | 196 | 0 |
| TOTAL | $88,234 | $20,522 | $25,051 | $29,497 | $7,548 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $88,234 | $20,522 | $25,051 | $29,497 | $7,548 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,586 | 801 | 969 | 1,518 | 936 |
| Accrued Expenses | 5,474 | 3,453 | 5,377 | 6,015 | 1,424 |
| Other current liabilities | 1,978 | N/A | N/A | N/A | N/A |
| TOTAL | $12,038 | $4,254 | $6,346 | $7,533 | $2,360 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,589 | 0 | 0 | 0 | 9,068 |
| TOTAL | $13,589 | $N/A | $N/A | $N/A | $9,068 |
| Total Liabilities | $25,627 | $4,254 | $6,346 | $7,533 | $11,428 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,019 | 1,320 | 1,320 | 1,320 | 1,237 |
| Common Shares | 11 | 1 | 1 | 1 | N/A |
| Retained earnings | -93,735 | -326,333 | -323,446 | -319,856 | -76,301 |
| Other shareholders' equity | 3 | -316 | -436 | -346 | 70,603 |
| TOTAL | $62,607 | $16,268 | $18,705 | $21,964 | $-3,880 |
| Total Liabilities And Equity | $88,234 | $20,522 | $25,051 | $29,497 | $7,548 |